Chronic Lymphatic Leukemia (CLL) Clinic
Director: Dr. Ohad Benjamini
Contact:
Phone: 03-5302386
Email (also for scheduling appointments): mirp.hemato-leukemia@sheba.gov.il
Fax: 03-5307746
Clinic Hours:
Sunday, Tuesday and Thursday: 7:00-15:30
Monday and Wednesday: 7:30-15:00
Location:
Cancer Center, Leukemia Cluster, Floor 3
In our clinic, patients with CLL undergo a range of diagnostic tests to ensure accurate diagnosis. These may include blood count, antigen markers, genetic profiling, cytogenetic evaluation, along with ZAP-70 and biopsy histology subtypes.
The treatment includes orally administered drugs, such as ibrutinib and venetoclax, or combination chemotherapy regimens that include rituximab (Mabthera®), obinutuzumab (GAZYVA®) and others, some of them in a research setting.
The clinic’s team also conducts studies with innovative and advanced generations of ibrutinib derivatives and antibodies.
The clinic's director, Dr. Ohad Benjamini, has a specialisation in CLL at MD Anderson, one of the world's leading cancer centers. He trained under the guidance of Dr. Michael J. Keating, a senior physician in the field of CLL who also developed the drug fludarabine - the first drug capable of curing the disease.
